ZeaVision, Inc.   Report issue

For profit Phase 4
Founded: Chesterfield MO United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2012
NCT02017418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ZeaVision, Inc. | ZeaVision, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 9